Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Louisville › NPI 1124005814
Physician

Martin, Alvin

Martin, Alvin was paid $21K by Medicaid between Mar 2022 and Mar 2022, across 22 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 21% of everything it billed.

33Billing provider infoMARTIN, ALVIN
LOUISVILLE, KY 40220
33aNPI1124005814assigned 12/23/2005
28Total paid$21K
24GClaims761
24DCodes billed22
24AFirst – last monthMar 2022 – Mar 2022
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022761$21K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 21% 30 30 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 10% 63 61 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 10% 63 61 $2K
81513 9.7% 26 26 $2K
87481 8.5% 52 26 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 8.4% 15 15 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 8.0% 49 48 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 3.7% 36 35 $772.48
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.7% 105 102 $755.75
84443 Thyroid stimulating hormone (TSH) 2.8% 35 35 $574.73
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2.7% 21 20 $565.38
80053 Comprehensive metabolic panel 1.8% 40 39 $376.39
10 more codes
86803 1.7% 28 $357.60
87086 Culture, bacterial; quantitative colony count, urine 1.7% 44 $347.89
86780 1.4% 23 $279.09
83036 Hemoglobin; glycosylated (A1C) <1% 21 $175.08
87340 <1% 19 $165.58
80061 Lipid panel <1% 13 $154.93
84439 <1% 18 $154.78
87186 <1% 12 $104.15
36415 Collection of venous blood by venipuncture <1% 34 $80.15
85652 <1% 14 $35.19

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.